바이오닉 아이 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Bionic Eye Market size is expected to reach USD 1295.71 Million in 2034 from USD 404.47 Million (2025) growing at a CAGR of 13.81% during 2026-2034.

The global bionic eye market has emerged as a groundbreaking segment within medical technology, focusing on restoring vision for individuals with severe visual impairments. Bionic eyes use advanced electronic implants and visual processing systems to stimulate the retina or optic nerve, enabling patients to perceive light and basic shapes. Rapid progress in biomedical engineering and neurotechnology has contributed to the development of innovative visual prosthetic systems, gradually transforming treatment options for vision loss.

Key growth drivers include increasing cases of retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration. Growing investments in medical research and the rising adoption of advanced implantable technologies are also supporting market development. Collaboration between technology companies, healthcare institutions, and research organizations has accelerated the advancement of bionic eye systems, improving their safety and functionality.

The future of the bionic eye market holds significant promise as researchers continue to refine implant technologies and neural interfaces. Advances in artificial intelligence, microelectronics, and wireless communication could enhance image processing and visual clarity for patients. As clinical trials expand and regulatory approvals increase, more patients may gain access to these innovative solutions. The continued pursuit of restoring functional vision is expected to drive further breakthroughs and market growth.

MARKET SEGMENTATION

By Type

• External Eye
• Implanted Eye

By End Use

• Hospitals
• Outpatient Facilities
• Research And Manufacturing

COMPANIES PROFILED

• Second Sight Medical Products LLC, NIDEK Co Ltd, Nano Retina Ltd, MetaModal LLC, Biomedical Technologies SL, Bionic Vision Technologies Pty Ltd, Pixium Vision SA, Monash Vision Group
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIONIC EYE MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. External Eye Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Implanted Eye Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIONIC EYE MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Outpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Research And Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIONIC EYE MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL BIONIC EYE INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Second Sight Medical Products LLC
  • 8.2.2 NIDEK Co. Ltd
  • 8.2.3 Nano Retina Ltd
  • 8.2.4 MetaModal LLC
  • 8.2.5 Biomedical Technologies S.L
  • 8.2.6 Bionic Vision Technologies Pty Ltd
  • 8.2.7 Pixium Vision SA
  • 8.2.8 Monash Vision Group